We respond to every inquiry. If you don't hear back within a week, please email directly — your note may have gotten lost.

© Ember Health. This page is intended for prospective investors and is not an offer to sell securities.
For investors

Healthcare captures what happens to patients. Ember captures what it's like to be one.

Ember is the patient experience data layer for oncology. This page is for investors getting to know us. We're not actively running a process — if you'd like to talk, there's a form near the bottom.


Why we're building this

Ember exists because we lived this.

Jason lost his wife Tracy. Forty-five months of caregiving. He watched the system track every scan, every lab, every visit — and never what it was like to be her. Or him.

Angeline lost her mother Lupe while pregnant, and then postpartum. Same gap, different family. The system recorded events. Never the uncertainty between appointments. Never the caregiver alone at midnight. Never the 2am scroll, the falling apart in the car, the repeating of the same update to family over and over.

Neither of us set out to build a data company. But the part of cancer that quietly breaks families doesn't exist in any chart. We're building it because someone has to.

What Ember is

Ember has two parts that depend on each other.

Ember Companion

A free, always-on companion for any family facing cancer. Reviewed by neuro-oncologists. There the moment a diagnosis lands, and through every chapter that follows. We started with glioblastoma — the indication with the highest emotional intensity and the highest caregiver burden — and we're expanding from there.

Ember Companion mobile app — a caregiver shares their mother's GBM diagnosis, and Ember responds with questions to bring to the neurosurgeon visit.
Ember Companion — patient & caregiver-facing
"It's like having someone sit with you after the appointment when everything finally hits." — Ember user

Ember Signal

The data layer that sits underneath. Every conversation, de-identified to HIPAA Safe Harbor, deepens a longitudinal dataset of patient and caregiver experience that pharma, payers, and researchers cannot get anywhere else. Claims and EHRs sit downstream of the chart. Ember sits upstream of every decision the chart never sees.

Ember Signal Digital Twin — aggregate caregiver responses to a pharma researcher's question about emotional challenges in the first three months after a GBM diagnosis.
Ember Signal — pharma, payer & researcher-facing

Where we are

Six months in, in glioblastoma alone:

3,397
Caregiving journeys engaged through Ember Companion
44,000+
Unprompted, emotionally authentic conversations
~70%
Repeat usage through treatment changes, hospice, and bereavement
50+
Countries — entirely without paid acquisition

Our work was accepted as an abstract at ASCO (545172) on the use of a patient-facing digital tool for glioblastoma outside scheduled clinic visits. More research collaborations are in flight.

Who's behind it

Jason and his late wife, Tracy.
Jason and Tracy

Jason Binder

Co-Founder & CEO

Jason spent 45 months caring for his wife, Tracy, during her battle with glioblastoma.

He lived the long arc of the disease, the constant recalibration, the late-night research, and the pressure to make decisions with incomplete clarity. He saw how fragmented the information was and how much responsibility fell on families to translate it into action.

With a background in data, research, and therapeutic development, he began building AI tools to help them think more clearly and prepare more intentionally. After seeing traction with his first tool, it was clear families needed this support.

Angeline and her late mother, Lupe.
Angeline and Lupe

Angeline Giammona

Co-Founder & GTM

While pregnant and parenting, Angeline spent 10 months caring for her mother, Lupe, during her glioblastoma diagnosis.

She lived the compression of time, the sudden immersion into new language, urgent decisions, and the expectation to function before feeling fully oriented. She saw how much effort families pour into researching, organizing, and supporting one another, and how little structure exists to help them make sense of it.

With a background in early-stage technology and product strategy, she became focused on the gap between information and implementation. She's dedicated her focus to helping families.

Advisors

Soma Sengupta, MD, PhD, MBA — Neuro-Oncology (Tufts, UNC, Cincinnati)

Greg Grevera — Patient advocacy & clinical strategy (Imvax, Servier, Jazz)

Erica Olenski, BCPA, CPXP — Patient experience (Finn Partners); pediatric caregiver

Danielle Ralic — Healthtech & analytics (Ancora.ai, ZS, Deloitte)

Full bench available on request.

Who's backing us

[Anchor Investor Name]
Lead investor — pre-seed

Additional angels and operator-investors named on request.

If you'd like to talk

Leave your details and we'll be in touch within a few days. If you'd rather email directly: angeline@emberhealth.ai or jason@emberhealth.ai.